Inactive Instrument

Beleave Inc. Stock price Canadian Securities Exchange

Equities

BE

CA0775611084

Pharmaceuticals

Sales 2018 - Sales 2019 2.37 3.23 Capitalization 30.37M 41.28M
Net income 2018 -12M -16.31M Net income 2019 -33M -44.85M EV / Sales 2018 -
Net cash position 2018 5.2M 7.07M Net Debt 2019 10.32M 14.02M EV / Sales 2019 17,137,012 x
P/E ratio 2018
-4.72 x
P/E ratio 2019
-0.76 x
Employees -
Yield 2018 *
-
Yield 2019
-
Free-Float 98.39%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Founder - 00-05-25
Chief Tech/Sci/R&D Officer - 15-12-14
Director/Board Member - 18-10-23
Members of the board TitleAgeSince
Chief Tech/Sci/R&D Officer - 15-12-14
Founder - 00-05-25
Director/Board Member - 18-10-23
More insiders
Beleave Inc. is a Canada-based cannabis company. Through its wholly owned subsidiary, Beleave Kannabis Corp, the Company is a license holder and producer of cannabis, which includes cultivation, processing, medical sales and research. Its segment includes Cannabis Products and Patient Network. Its Cannabis Products segment is a licensed producer of marihuana for medical purposes. Its Patient Network segment is a patient network of medical cannabis services. It cultivates cannabis flower, oil and extracts for medical and recreational markets. Its product line includes cannabis-infused products, oils and vape pens. The Company operates a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.
More about the company
  1. Stock
  2. Equities
  3. Stock Beleave Inc.
  4. Stock Beleave Inc. - Canadian Securities Exchange